S1 Ep220: Exploring The Future of Artificial Intelligence and Thoracic Oncology
About this episode
Chinmay Jani, MD discusses the integration of artificial intelligence in thoracic oncology and ongoing research initiatives at the University of Miami.
In a special edition of Oncology On the Go, Chinmay Jani, MD, joined CancerNetwork® in the studio to speak about different research initiatives he is involved with across precision oncology. He discussed ongoing work dedicated to validating and applying artificial intelligence (AI)–based tools in clinical work as well as overcoming immunotherapy resistance among patients with lung cancer. Jani, chief fellow in Hematology and Oncology at University of Miami Sylvester Comprehensive Cancer Center, first detailed findings from a study he presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting evaluating AI decision support in the context of EGFR- mutated non–small cell lung cancer (NSCLC). Although AI systems aligned with expert decision-making in frontline treatment, significant divergence was observed in second-line care, highlighting a need for more rigorous validation and clinical safeguards when integrating AI into oncologic decision-making. Improving documentation and using tools more ethically, Jani said, will also be critical for future applications of AI in field. Jani also spoke about the rapidly evolving thoracic oncology field based on research…
More episodes of Oncology On The Go
- S1 Ep225: How Will Orca-T Impact the Hematologic Oncology Paradigm?
- S1 Ep224: Managing Insomnia in Cancer Care: Sleep Hygiene, CBT-I, and Medications
- S1 Ep222: How Does a Death Doula Support Patients With Cancer?
- S1 Ep223: Optimizing Frontline Selection and Treatment-Free Remission in CML
- S1 Ep221: Redefining Lymphoma Standards of Care: Top Datasets From ASCO and EHA 2026
- S1 Ep219: Navigating Personality Disorders in Cancer Care
Explore listener stats, chart rankings, contacts and more on the Oncology On The Go podcast page.